Michael Kantrowitz, Piper Sandler chief investment strategist, joins 'The Exchange' to discuss the markets and how to ...

We recently published a list of 10 AI Stocks on Latest News and Ratings. In this article, we are going to take a look at ...

ImmunityBio (NASDAQ:IBRX) has been upgraded to Overweight from Neutral at Piper Sandler due to strong commercial momentum for ...

Although the FDA’s Refusal to File (RTF) letter for ANKTIVA in BCG unresponsive papillary NMIBC was a setback, Piper Sandler ...

MINNEAPOLIS, April 09, 2025--Piper Sandler Companies (NYSE: PIPR), a leading investment bank, completes its 49th semi-annual Taking Stock With Teens® survey in partnership with DECA. The Piper ...

today announced it will participate in the Piper Sandler Global Exchange & Trading Conference on Thursday, June 5, 2025. Tradeweb CEO Billy Hult will participate in a fireside chat at 11:30am ...

Five Point Infrastructure is working with investment bankers at Piper Sandler on the sale effort. The process is in its early ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

ImmunityBio (NASDAQ:IBRX) has been upgraded to Overweight from Neutral at Piper Sandler due to strong commercial momentum for its lead candidate Anktiva. The company’s successful launch of ...